PSMB5 mRNA overexpression has also been observed in bortezomib-resistant hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7) treated with stepwise increasing concentrations of bortezomib over ~6 months[45]. This evidence concerns the gene PSMB5 and hepatocellular carcinoma.